When COVID Drug Studies End Up in EMF Research: A Database Reality Check
About this episode
This episode explores a case study of a COVID-19 antiviral drug trial misclassified as EMF research, highlighting issues in research database accuracy.
What happens when a COVID-19 antiviral drug trial gets misclassified as electromagnetic field research? This episode explores a fascinating case study in research database accuracy. I examine how the RECOVERY trial -- which tested molnupiravir and nirmatrelvir-ritonavir in over one thousand COVID patients -- somehow ended up categorized as EMF research. This mix-up reveals important lessons about research integrity, database management, and why careful verification matters in health science. In This Episode The RECOVERY trial's actual findings on COVID antivirals How research databases can go wrong Why proper study categorization matters for health research Featured Study Read the full study: From subsea power cable to small-spotted catshark Scyliorhinus canicula: Behavioural effects of electromagnetic fields in tank experiments See all studies at shieldyourbody.com/research
More episodes of The Healthier Tech Podcast
- How Turtle Navigation Reveals Your EMF Vulnerability
- When EMF Actually Helps: Surprising Brain Benefits from Power Line Frequencies
- When Magnetic Fields Heal: The Surprising Science of EMF Nerve Repair
- How Power Line Frequency Can Change Brain Function: New Worm Study Reveals Hidden EMF Effects
- When EMF Actually Helps: Surprising Alzheimer’s Research Findings
- How EMF Disrupts Learning: What Flatworms Teach Us About Memory Formation
Explore listener stats, chart rankings, contacts and more on the The Healthier Tech Podcast podcast page.